Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
qingyuan zhang, MD
CONTACT
Lead
Sinocelltech Ltd.
This open label,single-arm multicenter phase II study is designed to evaluate Objective Response Rate (ORR) in advanced triple receptor negative breast cancer treated with anti-EGFR monoclonal antibody SCT200.
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted